The
PRIMARY score is a 5-category scale developed to identify clinically significant
intraprostate malignancy (csPCa) on 68Ga-prostatespecific membrane antigen
(PSMA) PET/CT (68Ga-PSMA PET) using a combination of anatomic site, pattern,
and intensity.
